Dealcast examines Linde/Praxair regulatory woes

14 September 2018 - 12:00 am UTC

Dealcast is a podcast covering activism, M&A, ECM and other corporate activity. Two years after talks began, Linde [ETR:LIN] and Praxair [NYSE:PX] are still trying to secure two major regulatory clearances for their merger.

Chinese approval from SAMR is due within weeks, while the FTC may only clear the deal if the parties exceed their divestiture revenue cap. But with a 24 October deadline approaching, is the industrial gas deal going to run out of steam?

Brandon Zero tells Julie-Anna Needham why the antitrust approvals are proving to be a headache for the companies.

Listen here to the podcast on Soundcloud and here to listen through  iTunes